Vol. XVIII · Free shipping $75+ · Read the collection
Login Register
Feature · Product Review
foxo4-dri patent

foxo4-dri patent The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOX04-DRI - Apollo Peptide Sciences

FOX04 DRI Apollo Peptide Sciences FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress FOXO4 DRI Peptide 10 mg FOX04 DRI 10mg Battle Born Peptides

SKU: 63342914776 · From www.marsberger-treibhaus.de

4.3
USD22.55 USD56.55

Pay in 4 interest-free payments of $5.64 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

Common sizes include 2mg, 3mg, 5mg, and 10mg

foxo4-dri patent The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOX04-DRI - Apollo Peptide Sciences

Who is AOD-9604 For

foxo4-dri patent The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOX04-DRI - Apollo Peptide Sciences

Bebu, I., Braffett, B

foxo4-dri patent The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOX04-DRI - Apollo Peptide Sciences

Mar 11 2021;22(6)doi:10.3390/ijms22062834 Man AWC, Li H, Xia N

foxo4-dri patent The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOX04-DRI - Apollo Peptide Sciences
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

EllieMD

US$ 26.30

4.8 (17 reviews)

Dihexa 10mg

US$ 26.57

4.0 (16 reviews)

DIHEXA

US$ 22.78

4.1 (17 reviews)

Dihexa

US$ 22.15

4.9 (15 reviews)

recommand products